Medicinova (MNOV) Return on Capital Employed (2011 - 2025)
Medicinova's (MNOV) quarterly Return on Capital Employed came in at 31.04% in Q4 2025, down 758.0% year-on-year from 4.72% in Q4 2024, and down 5.28% on a QoQ basis from 29.48% in Q3 2025.
Medicinova (MNOV) Return on Capital Employed (2011 - 2025) Analysis & Trends
Medicinova (MNOV) has 15 years of Return on Capital Employed data on file, last reported at 31.04% in Q4 2025.
- On a quarterly basis, Return on Capital Employed fell 758.0% year-over-year to 31.04% in Q4 2025; TTM through Dec 2025 was 31.04%, a 758.0% decrease from a year earlier, with the FY2025 full-year figure at 28.3%, down 649.0% from the prior year.
- Return on Capital Employed for Q4 2025 stood at 31.04%, down from 29.48% in the prior quarter.
- Over the last five years, Return on Capital Employed for MNOV reached as high as 11.79% in Q4 2021 and fell as low as 31.04% in Q4 2025.
- Historically, Return on Capital Employed has averaged 19.15% across 5 years, with a median of 17.34% in 2022.
- Across the five-year window, Return on Capital Employed jumped 733 bps in 2021 and plunged 1084 bps in 2025, its largest moves.
- Year by year, Return on Capital Employed stood at 11.79% in 2021, then sank by 70 bps to 20.02% in 2022, then gained by 23 bps to 15.49% in 2023, then plunged by 51 bps to 23.46% in 2024, then tumbled by 32 bps to 31.04% in 2025.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 31.04% in Q4 2025, 29.48% in Q3 2025, and 27.44% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | Medicinova | 64.48 Mn | 64.48 Mn | 4,754.00 | -31.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -31.04% |
| Sep 30, 2025 | -29.48% |
| Jun 30, 2025 | -27.44% |
| Mar 31, 2025 | -24.49% |
| Dec 31, 2024 | -23.46% |
| Sep 30, 2024 | -21.14% |
| Jun 30, 2024 | -16.60% |
| Mar 31, 2024 | -16.23% |
| Dec 31, 2023 | -15.49% |
| Sep 30, 2023 | -16.22% |
| Jun 30, 2023 | -19.96% |
| Mar 31, 2023 | -20.28% |
| Dec 31, 2022 | -20.02% |
| Sep 30, 2022 | -17.93% |
| Jun 30, 2022 | -16.74% |
| Mar 31, 2022 | -16.21% |
| Dec 31, 2021 | -11.79% |
| Sep 30, 2021 | -12.58% |
| Jun 30, 2021 | -12.18% |
| Mar 31, 2021 | -13.65% |